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ALLOTRANSPLANTATION of pancreatic islets has been used with variable success to treat insulin-
dependent Type I diabetes mellitus (IDDM).I The recent 
reports of long-term insulin-free existence following encap-
sulated2 or delayed3 islet cell transplantation in diabetic 
recipients have paved the way for its successful Qinical 
application. However, its global implementation will be 
impeded by the acute shortage of cadaveric donors, which 
has fomented our interest in the search for alternative 
sources of pancreata. Nonhuman primates (chimpanzees, 
baboons, etc.) by sharing many physiological and genetic 
characteristics with Homo Sapiens, are a reasonable alter-
native as donors for xenogeneic islet cell transplantation. 
The present study was designed to investigate the feasibility 
of using baboon pancreata to obtain viable and functional 
islets for future xenotransplantation. 
MATERIALS AND METHODS 
Animals 
Nine healthy juvenile baboons (Pappio annllbis) screened for all 
known viral and microbial infections were obtained from the 
Southwest Foundation for Biomedical Research, San Antonio, 
Texas. They were housed at the University of Pittsburgh, Monte-
fiore Hospital Animal Facilities. Male athymic nude (nu/nu) mice 
were obtained from Harlan Sprague-Dawley. Indianapolis, Ind, 
maintained in the pathogen-free facility al the University of 
Pittsburgh, and used at 6 to 8 weeks of age. 
Isolation of Pancreatic Islets 
Islets were isolated by a modification of the automated method 
described elsewhere.· They were subsequently purified by density 
centrifugation. The methods of dithizone staining and trypan blue 
dye exclusion were used to assess islet purity. viability, and yield. 
Dynamic perifusion assays were used to further assess their viability 
and in vitro functional capacity. 
Reversal of Diabetes in Nude Mice 
Hyperglycemia was induced in nude mice by a single IV injection of 
streptozolocm (STZ; 185 mg/kg/animal). The animals were consid-
ered diabetic when their blood glucose levels were found to be 
>250 mg;dL. Freshly isolated baboon islets (600 IEq) were trans-
planted 2 10 3 days post-STZ treatment beneath the left renal 
capsule. A reduction in blood glucose levels to < 150 mg/dL was 
considered as an indication of reversal of diabetes. An intraperi-
toneal glucose tolerance test (IPGTT) was performed approxi-
mately 5 weeks after islet cell transplantation to evaluate their 
function under stress. Unilateral nephrectomy of the graft-bearing 
kidney was eventually carried out to verify the function of the 
transplanted islets and the chemical destruction of the native 
pancreas. Insulin and glucagon content of the transplanted islets 
within the nephrectomized specimens were assessedby-i~ 
histochemistry and by Northern blotting. 
RESULTS AND DISCUSSION 
Islets were isolated from the pancreata of nine baboons 
who, based on their age, have been arbitrarily divided into 
two groups; group I: donors <2 years of age; group II: 
donors >4 years of age (Table 1). Pancreatic islet cell yields 
from baboons in both groups were comparable to those 
obtained form human cadaveric donors.3 When tested in in 
vitro dynamic perifusion assays, islets isolated from the 
pancreata of animals in group II responded efficiently to 
both glucose and caffeine stimulation. On the contrary, 
islets isolated from the pancreata of group I animals 
responded only to caffeine but not to glucose challenge in in 
vitro functional assays. This observation is similar to that 
made previously in the islets obtained from human pediat-
ric donors. Implantation of baboon islets under the renal 
capsule of diabetic athymic nude mice led to restoration of 
eugJycemic status in 36 of 40 (90%) of mice, with prompted 
reversal of hyperglycemia following intraperitoneal glucose 
challenge (lPGTI). The functional status of transplanted 
islets was further confirmed by unilateral nephrectomy of 
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Table 1. Cell Yield and Purity of Islets Isolated From Baboon Pancreata 
Donor age 
Groups (range: yr) 
I 1-2 
1/ 4-18 
Results are expressed as x '" SO. 
'Cold Ischemia time 
Pancreas 
n weight (g) 
7 31.2::: 16.2 
2 11.1 :': 0.76 
1 Estimated number of Islets With an average diameter of 150 1'. 
Clr(h) 
4.0:': 2.0 
5.5:': 3.4 
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Islets (IEq)t Islets/gram Purity 
(X10') (X103) (%) 
1.46:,: 0.5 5.3:': 1.3 85.0:,: 10.0 
0.80:': 0.1 6.9:': 0.4 86.4 :': 2.8 
3385 
1" 
.. 
3386 
the graft-bearing kidney, which precipitated reappearance 
of diabetes. Examination of transplanted islets in the ne-
phrectomized specimen revealed the presence of granu-
lated f3 cells that stained positively for insulin and glucagon. 
Furthermore, RNA obtained from transplanted islets, when 
immobilized onto a PVDF membrane and hybridized with 
insulin-specific peroxidase-based chemiluminescent probe, 
showed positive bands suggesting the presence of insulin 
mRNA. 
Because viable islets with acceptable purity and yield can 
be obtained from baboon pancreata, it is tempting to 
speculate that barring immunologic impedance, they may 
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be considered for xenotransplantation to treat humans with 
IDDM. 
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